Chase AIPricingFAQs
Display currency
Loading news…

Corstasis Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Henderson, Nevada, United States Founded 2018 1-10 employees For Profit

Corstasis Therapeutics offers therapeutic options for fluid overload recovery associated with congestive heart failure and kidney diseases.

Corstasis Therapeutics was acquired by Esperion in 2026 for $75M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
1
Patents granted
0
Trademarks
0
IT spend
$34K

Company Info

Founded
2018
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
News articles
31
HQ
Henderson, Nevada, United States
Region
Western US
Exit date
Mar 3, 2026

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0.3
Trend (30d)
-0.4
Trend (90d)
-2.8
Last leadership hire
Sep 11, 2025

Key People at Corstasis Therapeutics

Founder, Chairman, and Chief Executive Officer
Vice President of Medical Affairs

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Corstasis Therapeutics

Loading news…

FAQs about Corstasis Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Corstasis Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments